Translational studies to test potential therapies for patients with primary biliary cirrhosis
MASON, Andrew L
5 enregistrements totalisant 2,554,348.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Instituts de recherche en santé du Canada | $2,554,348 | 5 enregistrements |
Enregistrements
Pilot study of emtricitabine, tenofovir alafenamide and raltegravir for patients with primary biliary cholangitis
Pilot study of highly active anti-retroviral therapy for patients with primary biliary cirrhosis
Isolation of a novel human retrovirus associated with primary biliary cirrhosis and fulfillment of koch's postulates in vitro
The specific objective of this funding opportunity is: To harness the power of new technologies and interventions to prevent the onset of cancer and/or reduce its severity though early detection wh...